Hydrochloric Acid → 3-[5-(3-Hydroxy-8-aza-bicyclo[3.2.1]octane-8-carbonyl)-benzoimidazol-1-yl]-propionitrile
반응식
[C:1]([CH2:3][CH2:4][N:5]1[C:9]2[CH:10]=[CH:11][C:12]([C:14]([OH:16])=O)=[CH:13][C:8]=2[N:7]=[CH:6]1)#[N:2].C1C=CC2N(O)N=NC=2C=1.Cl.CC[N:30]([CH:34]([CH3:36])[CH3:35])[CH:31]([CH3:33])[CH3:32].CCN=C=NCCCN(C)C.Cl.CN([CH:52]=[O:53])C>>[OH:53][CH:52]1[CH2:35][CH:34]2[N:30]([C:14]([C:12]3[CH:11]=[CH:10][C:9]4[N:5]([CH2:4][CH2:3][C:1]#[N:2])[CH:6]=[N:7][C:8]=4[CH:13]=3)=[O:16])[CH:31]([CH2:32][CH2:36]2)[CH2:33]1참가 물질
7
반응물 6
생성물 1
실험 절차
To a solution of 1-(2-cyanoethyl)-1H-benzoimidazole-5-carboxylic acid (0.25 g, 1.16 mmol) in DMF (2.5 mL) was added with stirring HOBt (0.17 g, 1.27 mmol) followed by exo-nortropinol hydrochloride (0.21 g, 1.27 mmol), DIPEA (0.45 g, 3.48 mmol). EDCl.HCl was then added and it was stirred at room temperature for 12 h. The solvent was then evaporated and to the residue diluted with water (5 mL) and extracted with CH2Cl2. The organic phase was washed with brine solution, dried (Na2SO4) and the solvent evaporated. The residue was purified by preparative HPLC which afforded 0.26 g (67%) of 3-[5-(3-Hydroxy-8-aza-bicyclo[3.2.1]octane-8-carbonyl)-benzoimidazol-1-yl]-propionitrile. MS-ESI m/z 325 (M+1).
후처리
- customThe solvent was then evaporated and to the residue
- additiondiluted with water (5 mL)
- extractionextracted with CH2Cl2
- washThe organic phase was washed with brine solution
- dry with materialdried (Na2SO4)
- customthe solvent evaporated
- customThe residue was purified by preparative HPLC which
출처 및 근거
- ORD 기록
- ord-70da5a04389a435099296b11e06fea50
- 출처 데이터셋
- uspto-grants-2011_11
- 특허 번호
- US08053431B2
반응 노트
불러오는 중…